Trials / Unknown
UnknownNCT04470102
Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
A Randomised Controlled Pilot Trial: Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Objective of the study: to evaluate whether edge-to-edge technique improves clinical and hemodynamic results in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy.
Detailed description
A randomised controlled pilot trial to evaluate whether edge-to-edge technique improves clinical and hemodynamic results in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy. Patients with proven hypertrophic cardiomyopathy and resting left ventricle outflow tract obstruction underwent septal myectomy. If patients were suitable for both surgical techniques, they were randomized to septal myectomy + edge-to-edge mitral valve repair or isolated septal myectomy. All surgeons were experienced at least 50 related procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | mitral valve repair by edge-to-edge technique | transaortic access for mitral valve repair edge-to-edge |
| PROCEDURE | Septal myectomy | isolated extended septal myectomy |
Timeline
- Start date
- 2020-03-12
- Primary completion
- 2021-01-31
- Completion
- 2022-01-31
- First posted
- 2020-07-14
- Last updated
- 2020-07-21
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04470102. Inclusion in this directory is not an endorsement.